Filing Details

Accession Number:
0001787306-22-000077
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-22 19:06:14
Reporting Period:
2022-11-18
Accepted Time:
2022-11-22 19:06:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1787306 Arcutis Biotherapeutics Inc. ARQT Pharmaceutical Preparations (2834) 812974255
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1798679 Masaru Matsuda C/O Arcutis Biotherapeutics, Inc.
3027 Townsgate Road, Suite 300
Westlake Village CA 91361
See Remark No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-18 4,875 $0.00 21,255 No 4 A Direct
Common Stock Disposition 2022-11-21 1,720 $18.19 19,535 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents performance stock units ("PSUs") initially granted on January 3, 2022, that were subject to a performance-based vesting condition. The vesting condition was determined to be satisfied on November 18, 2022. The PSUs will vest fully on May 27, 2025, subject to the Reporting Person's continued service to the Issuer on such vesting date.
  2. Includes 13,300 Restricted Stock Units ("RSUs").
  3. Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the PSUs, the shares were sold upon the vesting of the PSUs solely to cover applicable withholding taxes.